8
Participants
Start Date
August 7, 2019
Primary Completion Date
December 5, 2019
Study Completion Date
April 11, 2020
Outpatient Dinoprostone 10mg
Dinoprostone (10 mg) is a vaginal insert approved to start and/or continue the ripening of the cervix in pregnant women who are at or near the time of delivery and in whom there is a medical reason for inducing (bringing on) labor. Women randomized to the outpatient cervical ripening group will be administered the drug prior to their induction and discharged after monitoring and physician approval. They will return for their schedule induction.
Inpatient Dinoprostone 10 mg
Dinoprostone (10 mg) is a vaginal insert approved to start and/or continue the ripening of the cervix in pregnant women who are at or near the time of delivery and in whom there is a medical reason for inducing (bringing on) labor. Women who are randomized to the inpatient cervical ripening group will be administered the drug prior to their induction and remain hospitalized.
Dixie Regional Medical Center, St. George
Collaborators (1)
Ferring Pharmaceuticals
INDUSTRY
Intermountain Health Care, Inc.
OTHER